Patel Sujal M 4
4 · Nautilus Biotechnology, Inc. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
2024-03-11$2.84/sh+12,044$34,216→ 10,064,488 total - Purchase
Common Stock
2024-03-08$2.99/sh+2,430$7,262→ 10,052,444 total
Holdings
- 5,280,476(indirect: By LLC)
Common Stock
- 1,814,035(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 2,430 shares purchased in the price range of $2.96 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 12,044 shares purchased in the price range of $2.75 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
- [F4]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.